AEP
64
5
EL
61
3
ADP
58
-8
STZ
44
-3
IR
55
-11
AMT
25
-5
JBHT
63
3
MO
51
-6
ADI
72
2
MDLZ
28
6
APD
47
-3
TGNA
56
-2
GME
72
-3
DLTR
62
-4
LB
31
-2
EFX
52
2
NOV
48
-4
MPC
36
-3
CNX
46
-3
HCA
59
-3
AEP
64
5
EL
61
3
ADP
58
-8
STZ
44
-3
IR
55
-11
AMT
25
-5
JBHT
63
3
MO
51
-6
ADI
72
2
MDLZ
28
6
APD
47
-3
TGNA
56
-2
GME
72
-3
DLTR
62
-4
LB
31
-2
EFX
52
2
NOV
48
-4
MPC
36
-3
CNX
46
-3
HCA
59
-3
Financhill
Back

Fidelity Disruptive Finance ETF Vs. Monopar Therapeutics, Inc. Sector Stock Comparison

Buy
74

FDFF
Fidelity Disruptive Finance ETF

Last Price:
$35.89
Seasonality Move:
4.29%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
74
Fidelity Disruptive Finance ETF (FDFF) is a Buy

Is Fidelity Disruptive Finance ETF a Buy, Sell or Hold?

  • The current Fidelity Disruptive Finance ETF [FDFF] share price is $35.86. The Score for FDFF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • FDFF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDFF Stock Price Chart

What is Fidelity Disruptive Finance ETF's stock price today?

  • The Fidelity Disruptive Finance ETF share price today is $35.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDFF is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

FDFF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 59.75 Buy
Chaikin Money Flow: 113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.73 - 35.57) Buy
Bollinger Bands (100): (34.78 - 37.46) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -36886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

FDFF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.66 Buy
20-day SMA: 34.97 Buy
50-day SMA: 34.98 Buy
200-day SMA: 36.21 Sell
8-day EMA: 35.54 Buy
20-day EMA: 35.18 Buy
50-day EMA: 35.27 Buy
200-day EMA: 35.89 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.2 Sell
20-day SMA: 79.37 Sell
50-day SMA: 82.12 Sell
200-day SMA: 52.13 Buy
8-day EMA: 72.25 Sell
20-day EMA: 76.67 Sell
50-day EMA: 77.13 Sell
200-day EMA: 56.56 Buy

Fidelity Disruptive Finance ETF Earnings Growth & FDFF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Fidelity Disruptive Finance ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):